Mental health impact by COVID-19 in hospitalized patients sample in Mexico City

One of the consequences of pandemic is the increase in the prevalence of mental alterations such as anxiety, depression and stress. Since here, we aimed to determinate through a transversal and observa-tional study prevalence of stress, anxiety and depression within hospital-ized patients by COVID-1...

Descripción completa

Detalles Bibliográficos
Autores: Maya Piña, Lucía Verónica, Barbosa Cobos, Rosa Elda, Lugo Zamudio, Gustavo Esteban, Chacón Abril, Karla Lorena, Padrón Ramírez, Mayela, Jiménez Jiménez, Xóchitl, Vuelvas Olmos, César Rubén, Cortés Álvarez, Nadia Yanet, Jiménez Jiménez, Saúl
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universidad de Murcia
Repositorio:DIGITUM. Depósito Digital Institucional de la Universidad de Murcia
OAI Identifier:oai:digitum.um.es:10201/125525
Acceso en línea:https://doi.org/10.6018/analesps.502711
http://hdl.handle.net/10201/125525
Access Level:acceso abierto
Palabra clave:DASS-21
Anxiety
Stress
Depression
COVID-19
Ansiedad
Estrés
Depresión
CDU::1 - Filosofía y psicología::159.9 - Psicología
Descripción
Sumario:One of the consequences of pandemic is the increase in the prevalence of mental alterations such as anxiety, depression and stress. Since here, we aimed to determinate through a transversal and observa-tional study prevalence of stress, anxiety and depression within hospital-ized patients by COVID-19 as well as their likely association with the emo-tional impact received by relatives with hospitalized patients by COVID-19. Forty-five COVID-19 hospitalized patients with mean age of 54.4 ± 9.6 years and fifty-five relatives with mean age of 43.2 ± 11.8 years an-swered a questions battery and DASS-21 survey. Our results revealed high prevalence of depression, anxiety and stress assessed by DASS-21 sub-scales. We also identified risk factors associated with the emotional health such as age (< 50 years: depression OR = 2.99 [1.31, 6.80], p < .05 and anxiety OR = 2.83 [1.15, 6.93], p < .05), by gender (female: anxiety OR = 4.13 [1.57, 10.89], p < .05 and stress OR = 5.38 [2.27, 12.8], p < .05), by group of study (relatives: depression OR = 3.83 [1.63, 8.96]; p < .05, anxie-ty OR = 3.60 [1.46, 8.88]; p < .05 and stress OR = 3.30 [1.41, 7.70]; p < .05). Additionally, female gender and low socioeconomic status in patients (β = 3.23; 1.96) and relatives (β = 1.86; 2.31) were associated with higher scores in anxiety (p < .05) and stress (p < .05). We concluded that our sample of COVID-19 patients maintain a high prevalence of mental altera-tions and age, gender and socioeconomic status modify the magnitude of these disorders.